Adipose-derived stem cells: A review of signaling networks governing cell fate and regenerative potential in the context of craniofacial and long bone skeletal repair

International Journal of Molecular Sciences

Volumn 15, Issue 6, 2014, Pages 9314-9330

  Senarath Yapa, Kshemendra ^a   McArdle, Adrian ^a   Renda, Andrea ^b   Longaker, Michael T ^a   Quarto, Natalina ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

ASCs; Bone; Endochondral; Intramembranous; Ossification; Osteogenesis; Regeneration; Scaffolds; Signaling; Stem cells

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; CADHERIN; CD34 ANTIGEN; CD36 ANTIGEN; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; SONIC HEDGEHOG PROTEIN; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR MAF; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; WNT PROTEIN; SIGNAL PEPTIDE;

ADIPOSE DERIVED STEM CELL; BONE DEFECT; BONE DEVELOPMENT; BONE REMODELING; CARTILAGE CELL; CELL FATE; CELL REGENERATION; CELLULAR STRESS SIGNAL; CHONDRODYSPLASIA; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MALFORMATION; ENCHONDRAL OSSIFICATION; FRACTURE HEALING; GENETIC MANIPULATION; HOMEOSTASIS; HUMAN; INCIDENCE; OSTEOCLASTOGENESIS; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; ADIPOSE TISSUE; ANIMAL; BONE REGENERATION; CYTOLOGY; METABOLISM; PROCEDURES; SIGNAL TRANSDUCTION; STEM CELL; TISSUE SCAFFOLD;

ADIPOSE TISSUE; ANIMALS; BONE REGENERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS; SIGNAL TRANSDUCTION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84901411569     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15069314     Document Type: Review

References (104)

1. Health, United States, 2007: With Chartbook on Trends in the Health of Americans; Report No.: 2007-1232; National Center for Health Statistics: Hyattsville, MD, USA, 2007.
2. Levi, B.; Longaker, M.T. Concise review: Adipose-derived stromal cells for skeletal regenerative medicine. Stem cells 2011, 29, 576-582.
3. Steiner, C.; Elixhauser, A.; Schnaier, J. The healthcare cost and utilization project: An overview. Eff. Clin. Pract. 2002, 5, 143-151.
4. Olsen, B.R.; Reginato, A.M.; Wang, W. Bone development. Annu. Rev. Cell Dev. Biol. 2000, 16, 191-220.
5. Heng, B.C.; Cao, T.; Stanton, L.W.; Robson, P.; Olsen, B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro.J. Bone Miner. Res. 2004, 19, 1379-1394.
6. Rice, D.P. Craniofacial sutures: Development, disease and treatment. Preface. Front. Oral Biol. 2008, 12, 1-21.
7. Long, F.; Ornitz, D.M. Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 2013, 5, a008334.
8. DeLise, A.M.; Fischer, L.; Tuan, R.S. Cellular interactions and signaling in cartilage development. Osteoarthr. Cartil. 2000, 8, 309-334.
9. Stadler, H.S.; Higgins, K.M.; Capecchi, M.R. Loss of Eph-receptor expression correlates with loss of cell adhesion and chondrogenic capacity in Hoxa13 mutant limbs. Development 2001, 128, 4177-4188.
10. Pizette, S.; Niswander, L. Bmps are required at two steps of limb chondrogenesis: Formation of prechondrogenic condensations and their differentiation into chondrocytes. Dev. Biol. 2000, 219, 237-249.
11. Yoon, B.S.; Ovchinnikov, D.A.; Yoshii, I.; Mishina, Y.; Behringer, R.R.; Lyons, K.M. Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc. Natl. Acad. Sci. USA 2005, 102, 5062-5067.
12. Wagner, T.; Wirth, J.; Meyer, J.; Zabel, B.; Held, M.; Zimmer, J.; Pasantes, J.; Bricarelli, F.D.; Keutel, J.; Hustert, E.; et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 1994, 79, 1111-1120.
13. Akiyama, H.; Chaboissier, M.C.; Martin, J.F.; Schedl, A.; de Crombrugghe, B. The transcription factor SOX9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of SOX5 and SOX6. Genes Dev. 2002, 16, 2813-2828.
14. Barna, M.; Niswander, L. Visualization of cartilage formation: Insight into cellular properties of skeletal progenitors and chondrodysplasia syndromes. Dev. Cell 2007, 12, 931-941.
15. Maes, C.; Kobayashi, T.; Selig, M.K.; Torrekens, S.; Roth, S.I.; Mackem, S.; Carmeliet, G.; Kronenberg, H.M. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev. Cell 2010, 19, 329-344.
16. Gerber, H.P.; Vu, T.H.; Ryan, A.M.; Kowalski, J.; Werb, Z.; Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 1999, 5, 623-628.
17. Vu, T.H.; Shipley, J.M.; Bergers, G.; Berger, J.E.; Helms, J.A.; Hanahan, D.; Shapiro, S.D.; Senior, R.M.; Werb, Z. MMP-9/Gelatinase b is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93, 411-422.
18. Otto, F.; Thornell, A.P.; Crompton, T.; Denzel, A.; Gilmour, K.C.; Rosewell, I.R.; Stamp, G.W.; Beddington, R.S.; Mundlos, S.; Olsen, B.R.; et al. CBFA1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997, 89, 765-771.
19. Choi, J.Y.; Pratap, J.; Javed, A.; Zaidi, S.K.; Xing, L.; Balint, E.; Dalamangas, S.; Boyce, B.; van Wijnen, A.J.; Lian, J.B.; et al. Subnuclear targeting of RUNX/CBFA/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. USA 2001, 98, 8650-8655.
20. Ducy, P.; Starbuck, M.; Priemel, M.; Shen, J.; Pinero, G.; Geoffroy, V.; Amling, M.; Karsenty, G. A CBFA1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev. 1999, 13, 1025-1036.
21. Ducy, P.; Zhang, R.; Geoffroy, V.; Ridall, A.L.; Karsenty, G. OSF2/CBFA1: A transcriptional activator of osteoblast differentiation. Cell 1997, 89, 747-754.
22. Nakashima, K.; Zhou, X.; Kunkel, G.; Zhang, Z.; Deng, J.M.; Behringer, R.R.; de Crombrugghe, B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108, 17-29.
23. Zhou, X.; Zhang, Z.; Feng, J.Q.; Dusevich, V.M.; Sinha, K.; Zhang, H.; Darnay, B.G.; de Crombrugghe, B. Multiple functions of osterix are required for bone growth and homeostasis in postnatal mice. Proc. Natl. Acad. Sci. USA 2010, 107, 12919-12924.
24. St-Jacques, B.; Hammerschmidt, M.; McMahon, A.P. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 1999, 13, 2072-2086.
25. Long, F.; Chung, U.I.; Ohba, S.; McMahon, J.; Kronenberg, H.M.; McMahon, A.P. IHH signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 2004, 131, 1309-1318.
26. Boyden, L.M.; Mao, J.; Belsky, J.; Mitzner, L.; Farhi, A.; Mitnick, M.A.; Wu, D.; Insogna, K.; Lifton, R.P. High bone density due to a mutation in LDL-receptor-related protein 5. N. Engl. J. Med. 2002, 346, 1513-1521.
27. Gong, Y.; Slee, R.B.; Fukai, N.; Rawadi, G.; Roman-Roman, S.; Reginato, A.M.; Wang, H.; Cundy, T.; Glorieux, F.H.; Lev, D.; et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 2001, 107, 513-523.
28. Rodda, S.J.; McMahon, A.P. Distinct roles for hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133, 3231-3244.
29. Hu, H.; Hilton, M.J.; Tu, X.; Yu, K.; Ornitz, D.M.; Long, F. Sequential roles of hedgehog and Wnt signaling in osteoblast development. Development 2005, 132, 49-60.
30. Tu, X.; Joeng, K.S.; Nakayama, K.I.; Nakayama, K.; Rajagopal, J.; Carroll, T.J.; McMahon, A.P.; Long, F. Noncanonical Wnt signaling through G protein-linked PKCδ activation promotes bone formation. Dev. Cell 2007, 12, 113-127.
31. Tu, X.; Chen, J.; Lim, J.; Karner, C.M.; Lee, S.Y.; Heisig, J.; Wiese, C.; Surendran, K.; Kopan, R.; Gessler, M.; et al. Physiological notch signaling maintains bone homeostasis via RBPJK and hey upstream of NFATC1. PLoS Genet. 2012, 8, e1002577.
32. Hilton, M.J.; Tu, X.; Wu, X.; Bai, S.; Zhao, H.; Kobayashi, T.; Kronenberg, H.M.; Teitelbaum, S.L.; Ross, F.P.; Kopan, R.; et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 2008, 14, 306-314.
33. Heldin, C.H.; Miyazono, K.; ten Dijke, P. TGF-β signalling from cell membrane to nucleus through smad proteins. Nature 1997, 390, 465-471.
34. Bandyopadhyay, A.; Tsuji, K.; Cox, K.; Harfe, B.D.; Rosen, V.; Tabin, C.J. Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis. PLoS Genet. 2006, 2, e216.
35. Daluiski, A.; Engstrand, T.; Bahamonde, M.E.; Gamer, L.W.; Agius, E.; Stevenson, S.L.; Cox, K.; Rosen, V.; Lyons, K.M. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat. Genet. 2001, 27, 84-88.
36. Kokabu, S.; Gamer, L.; Cox, K.; Lowery, J.; Tsuji, K.; Raz, R.; Economides, A.; Katagiri, T.; Rosen, V. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol. Endocrinol. 2012, 26, 87-94.
37. Eswarakumar, V.P.; Monsonego-Ornan, E.; Pines, M.; Antonopoulou, I.; Morriss-Kay, G.M.; Lonai, P. The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 2002, 129, 3783-3793.
38. Montero, A.; Okada, Y.; Tomita, M.; Ito, M.; Tsurukami, H.; Nakamura, T.; Doetschman, T.; Coffin, J.D.; Hurley, M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Investig. 2000, 105, 1085-1093.
39. Ohbayashi, N.; Shibayama, M.; Kurotaki, Y.; Imanishi, M.; Fujimori, T.; Itoh, N.; Takada, S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002, 16, 870-879.
40. Quarto, N.; Behr, B.; Li, S.; Longaker, M.T. Differential FGF ligands and FGF receptors expression pattern in frontal and parietal calvarial bones. Cells Tissues Organs 2009, 190, 158-169.
41. Ornitz, D.M.; Itoh, N. Fibroblast growth factors. Genome Biol. 2001, 2, reviews3005.1-3005.2.
42. Jacob, A.L.; Smith, C.; Partanen, J.; Ornitz, D.M. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Dev. Biol. 2006, 296, 315-328.
43. Wilkie, A.O. Craniosynostosis: Genes and mechanisms. Hum. Mol. Genet. 1997, 6, 1647-1656.
44. Burke, D.; Wilkes, D.; Blundell, T.L.; Malcolm, S. Fibroblast growth factor receptors: Lessons from the genes. Trends Biochem. Sci. 1998, 23, 59-62.
45. Sarkar, S.; Petiot, A.; Copp, A.; Ferretti, P.; Thorogood, P. FGF2 promotes skeletogenic differentiation of cranial neural crest cells. Development 2001, 128, 2143-2152.
46. Behr, B.; Panetta, N.J.; Longaker, M.T.; Quarto, N. Different endogenous threshold levels of fibroblast growth factor-ligands determine the healing potential of frontal and parietal bones. Bone 2010, 47, 281-294.
47. Quarto, N.; Wan, D.C.; Kwan, M.D.; Panetta, N.J.; Li, S.; Longaker, M.T. Origin matters: Differences in embryonic tissue origin and Wnt signaling determine the osteogenic potential and healing capacity of frontal and parietal calvarial bones. J. Bone Miner. Res. 2010, 25, 1680-1694.
48. Caplan, A.I. Mesenchymal stem cells. J. Orthop. Res. 1991, 9, 641-650.
49. Pittenger, M.F.; Mackay, A.M.; Beck, S.C.; Jaiswal, R.K.; Douglas, R.; Mosca, J.D.; Moorman, M.A.; Simonetti, D.W.; Craig, S.; Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284, 143-147.
50. Rodbell, M. The metabolism of isolated fat cells. IV: Regulation of release of protein by lipolytic hormones and insulin. J. Biol. Chem. 1966, 241, 3909-3917.
51. Zuk, P.A.; Zhu, M.; Ashjian, P.; de Ugarte, D.A.; Huang, J.I.; Mizuno, H.; Alfonso, Z.C.; Fraser, J.K.; Benhaim, P.; Hedrick, M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 2002, 13, 4279-4295.
52. Zuk, P.A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J.W.; Katz, A.J.; Benhaim, P.; Lorenz, H.P.; Hedrick, M.H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 2001, 7, 211-228.
53. Gimble, J.M.; Katz, A.J.; Bunnell, B.A. Adipose-derived stem cells for regenerative medicine. Circ. Res. 2007, 100, 1249-1260.
54. Zuk, P.A. Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatr. Res. 2008, 63, 478-486.
55. Cowan, C.M.; Shi, Y.Y.; Aalami, O.O.; Chou, Y.F.; Mari, C.; Thomas, R.; Quarto, N.; Contag, C.H.; Wu, B.; Longaker, M.T. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat. Biotechnol. 2004, 22, 560-567.
56. Izadpanah, R.; Trygg, C.; Patel, B.; Kriedt, C.; Dufour, J.; Gimble, J.M.; Bunnell, B.A. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J. Cell Biochem. 2006, 99, 1285-1297.
57. Tucker, H.A.; Bunnell, B.A. Characterization of human adipose-derived stem cells using flow cytometry. Methods Mol. Biol. 2011, 702, 121-131.
58. Bourin, P.; Bunnell, B.A.; Casteilla, L.; Dominici, M.; Katz, A.J.; March, K.L.; Redl, H.; Rubin, J.P.; Yoshimura, K.; Gimble, J.M. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the international federation for adipose therapeutics and science (IFATS) and the international society for cellular therapy (ISCT). Cytotherapy 2013, 15, 641-648.
59. Casadei, A.; Epis, R.; Ferroni, L.; Tocco, I.; Gardin, C.; Bressan, E.; Sivolella, S.; Vindigni, V.; Pinton, P.; Mucci, G.; et al. Adipose tissue regeneration: A state of the art. J. Biomed. Biotechnol. 2012, 2012, 462543.
60. Chung, M.T.; Liu, C.; Hyun, J.S.; Lo, D.D.; Montoro, D.T.; Hasegawa, M.; Li, S.; Sorkin, M.; Rennert, R.; Keeney, M.; et al. Cd90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells. Tissue Eng. A 2013, 19, 989-997.
61. James, A.W.; Zara, J.N.; Zhang, X.; Askarinam, A.; Goyal, R.; Chiang, M.; Yuan, W.; Chang, L.; Corselli, M.; Shen, J.; et al. Perivascular stem cells: A prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Transl. Med. 2012, 1, 510-519.
62. Basmanav, F.B.; Kose, G.T.; Hasirci, V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008, 29, 4195-4204.
63. Jeon, O.; Song, S.J.; Yang, H.S.; Bhang, S.H.; Kang, S.W.; Sung, M.A.; Lee, J.H.; Kim, B.S. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem. Biophys. Res. Commun. 2008, 369, 774-780.
64. Zhang, S.; Doschak, M.R.; Uludag, H. Pharmacokinetics and bone formation by BMP-2 entrapped in polyethylenimine-coated albumin nanoparticles. Biomaterials 2009, 30, 5143-5155.
65. Dragoo, J.L.; Choi, J.Y.; Lieberman, J.R.; Huang, J.; Zuk, P.A.; Zhang, J.; Hedrick, M.H.; Benhaim, P. Bone induction by BMP-2 transduced stem cells derived from human fat. J. Orthop. Res. 2003, 21, 622-629.
66. Dragoo, J.L.; Lieberman, J.R.; Lee, R.S.; Deugarte, D.A.; Lee, Y.; Zuk, P.A.; Hedrick, M.H.; Benhaim, P. Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast. Reconstr. Surg. 2005, 115, 1665-1673.
67. Levi, B.; James, A.W.; Nelson, E.R.; Vistnes, D.; Wu, B.; Lee, M.; Gupta, A.; Longaker, M.T. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS One 2010, 5, e11177.
68. Levi, B.; Hyun, J.S.; Nelson, E.R.; Li, S.; Montoro, D.T.; Wan, D.C.; Jia, F.J.; Glotzbach, J.C.; James, A.W.; Lee, M.; et al. Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair. Stem Cells 2011, 29, 2018-2029.
69. Marie, P.J. Fibroblast growth factor signaling controlling osteoblast differentiation. Gene 2003, 316, 23-32.
70. Quarto, N.; Longaker, M.T. FGF-2 inhibits osteogenesis in mouse adipose tissue-derived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng. 2006, 12, 1405-1418.
71. Kwan, M.D.; Sellmyer, M.A.; Quarto, N.; Ho, A.M.; Wandless, T.J.; Longaker, M.T. Chemical control of FGF-2 release for promoting calvarial healing with adipose stem cells. J. Biol. Chem. 2011, 286, 11307-11313.
72. Quarto, N.; Wan, D.C.; Longaker, M.T. Molecular mechanisms of FGF-2 inhibitory activity in the osteogenic context of mouse adipose-derived stem cells (mASCs). Bone 2008, 42, 1040-1052.
73. Marie, P.J. Fibroblast growth factor signaling controlling bone formation: An update. Gene 2012, 498, 1-4.
74. Santos, M.I.; Reis, R.L. Vascularization in bone tissue engineering: Physiology, current strategies, major hurdles and future challenges. Macromol. Biosci. 2010, 10, 12-27.
75. Behr, B.; Tang, C.; Germann, G.; Longaker, M.T.; Quarto, N. Locally applied vascular endothelial growth factor a increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells 2011, 29, 286-296.
76. Miranville, A.; Heeschen, C.; Sengenes, C.; Curat, C.A.; Busse, R.; Bouloumie, A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 2004, 110, 349-355.
77. Planat-Benard, V.; Silvestre, J.S.; Cousin, B.; Andre, M.; Nibbelink, M.; Tamarat, R.; Clergue, M.; Manneville, C.; Saillan-Barreau, C.; Duriez, M.; et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004, 109, 656-663.
78. Behr, B.; Sorkin, M.; Lehnhardt, M.; Renda, A.; Longaker, M.T.; Quarto, N. A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model. Tissue Eng. A 2012, 18, 1079-1086.
79. Peterson, B.; Zhang, J.; Iglesias, R.; Kabo, M.; Hedrick, M.; Benhaim, P.; Lieberman, J.R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 2005, 11, 120-129.
80. Chou, Y.F.; Zuk, P.A.; Chang, T.L.; Benhaim, P.; Wu, B.M. Adipose-derived stem cells and BMP2: Part 1. BMP2-treated adipose-derived stem cells do not improve repair of segmental femoral defects. Connect. Tissue Res. 2011, 52, 109-118.
81. De Girolamo, L.; Arrigoni, E.; Stanco, D.; Lopa, S.; di Giancamillo, A.; Addis, A.; Borgonovo, S.; Dellavia, C.; Domeneghini, C.; Brini, A.T. Role of autologous rabbit adipose-derived stem cells in the early phases of the repairing process of critical bone defects. J. Orthop. Res. 2011, 29, 100-108.
82. Sheyn, D.; Kallai, I.; Tawackoli, W.; Cohn Yakubovich, D.; Oh, A.; Su, S.; Da, X.; Lavi, A.; Kimelman-Bleich, N.; Zilberman, Y.; et al. Gene-modified adult stem cells regenerate vertebral bone defect in a rat model. Mol. Pharm. 2011, 8, 1592-1601.
83. Carvalho, P.P.; Leonor, I.B.; Smith, B.J.; Dias, I.R.; Reis, R.L.; Gimble, J.M.; Gomes, M.E. Undifferentiated human adipose-derived stromal/stem cells loaded onto wet-spun starch-polycaprolactone scaffolds enhance bone regeneration: Nude mice calvarial defect in vivo study. J. Biomed. Mater. Res. Part A 2013, doi:10.1002/jbm.a.34983.
84. 2 glasses. Biomaterials 2003, 24, 1349-1356.
85. Fang, J.; Zhu, Y.Y.; Smiley, E.; Bonadio, J.; Rouleau, J.P.; Goldstein, S.A.; McCauley, L.K.; Davidson, B.L.; Roessler, B.J. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. USA 1996, 93, 5753-5758.
86. Lu, Z.; Roohani-Esfahani, S.I.; Wang, G.; Zreiqat, H. Bone biomimetic microenvironment induces osteogenic differentiation of adipose tissue-derived mesenchymal stem cells. Nanomedicine 2012, 8, 507-515.
87. Levi, B.; Hyun, J.S.; Montoro, D.T.; Lo, D.D.; Chan, C.K.; Hu, S.; Sun, N.; Lee, M.; Grova, M.; Connolly, A.J.; et al. In vivo directed differentiation of pluripotent stem cells for skeletal regeneration. Proc. Natl. Acad. Sci. USA 2012, 109, 20379-20384.
88. Hwang, N.S.; Varghese, S.; Lee, H.J.; Zhang, Z.; Elisseeff, J. Biomaterials directed in vivo osteogenic differentiation of mesenchymal cells derived from human embryonic stem cells. Tissue Eng. A 2013, 19, 1723-1732.
89. Stolzing, A.; Jones, E.; McGonagle, D.; Scutt, A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech. Ageing Dev. 2008, 129, 163-173.
90. Rossi, D.J.; Jamieson, C.H.; Weissman, I.L. Stems cells and the pathways to aging and cancer. Cell 2008, 132, 681-696.
91. Eto, H.; Suga, H.; Inoue, K.; Aoi, N.; Kato, H.; Araki, J.; Doi, K.; Higashino, T.; Yoshimura, K. Adipose injury-associated factors mitigate hypoxia in ischemic tissues through activation of adipose-derived stem/progenitor/stromal cells and induction of angiogenesis. Am. J. Pathol. 2011, 178, 2322-2332.
92. Lu, C.; Hansen, E.; Sapozhnikova, A.; Hu, D.; Miclau, T.; Marcucio, R.S. Effect of age on vascularization during fracture repair. J. Orthop. Res. 2008, 26, 1384-1389.
93. Suga, H.; Glotzbach, J.P.; Sorkin, M.; Longaker, M.T.; Gurtner, G.C. Paracrine mechanism of angiogenesis in adipose-derived stem cell transplantation. Ann. Plast. Surg. 2014, 72, 234-241.
94. De Barros, S.; Dehez, S.; Arnaud, E.; Barreau, C.; Cazavet, A.; Perez, G.; Galinier, A.; Casteilla, L.; Planat-Benard, V. Aging-related decrease of human ASC angiogenic potential is reversed by hypoxia preconditioning through ROS production. Mol. Ther. 2013, 21, 399-408.
95. Conboy, I.M.; Conboy, M.J.; Wagers, A.J.; Girma, E.R.; Weissman, I.L.; Rando, T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433, 760-764.
96. Loffredo, F.S.; Steinhauser, M.L.; Jay, S.M.; Gannon, J.; Pancoast, J.R.; Yalamanchi, P.; Sinha, M.; Dall'Osso, C.; Khong, D.; Shadrach, J.L.; et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 2013, 153, 828-839.
97. Gimble, J.M.; Guilak, F.; Bunnell, B.A. Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res. Ther. 2010, 1, 19.
98. Bellotti, C.; Stanco, D.; Ragazzini, S.; Romagnoli, L.; Martella, E.; Lazzati, S.; Marchetti, C.; Donati, D.; Lucarelli, E. Analysis of the karyotype of expanded human adipose-derived stem cells for bone reconstruction of the maxillo-facial region. Int. J. Immunopathol. Pharmacol. 2013, 26, 3-9.
99. Barba, M.; Cicione, C.; Bernardini, C.; Michetti, F.; Lattanzi, W. Adipose-derived mesenchymal cells for bone regereneration: State of the art. BioMed Res. Int. 2013, 2013, 416391.
100. Bianchi, F.; Maioli, M.; Leonardi, E.; Olivi, E.; Pasquinelli, G.; Valente, S.; Mendez, A.J.; Ricordi, C.; Raffaini, M.; Tremolada, C.; et al. A new nonenzymatic method and device to obtain a fat tissue derivative highly enriched in pericyte-like elements by mild mechanical forces from human lipoaspirates. Cell Transplant. 2013, 22, 2063-2077.
101. Lendeckel, S.; Jodicke, A.; Christophis, P.; Heidinger, K.; Wolff, J.; Fraser, J.K.; Hedrick, M.H.; Berthold, L.; Howaldt, H.P. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: Case report. J. Craniomaxillofac. Surg. 2004, 32, 370-373.
102. Thesleff, T.; Lehtimaki, K.; Niskakangas, T.; Mannerstrom, B.; Miettinen, S.; Suuronen, R.; Ohman, J. Cranioplasty with adipose-derived stem cells and biomaterial: A novel method for cranial reconstruction. Neurosurgery 2011, 68, 1535-1540.
103. Mesimaki, K.; Lindroos, B.; Tornwall, J.; Mauno, J.; Lindqvist, C.; Kontio, R.; Miettinen, S.; Suuronen, R. Novel maxillary reconstruction with ectopic bone formation by gmp adipose stem cells. Int. J. Oral Maxillofac. Surg. 2009, 38, 201-209.
104. Lindroos, B.; Suuronen, R.; Miettinen, S. The potential of adipose stem cells in regenerative medicine. Stem Cell Rev. 2011, 7, 269-291.